Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146640
Status:
COMPLETED
Last Update Posted:
2018-07-03
First Post:
2005-09-06
Brief Title:
Prednisone Timed-Release Tablet TRT Study Modified-Release MR Formulation of Prednisone Compared to Standard Immediate-Release IR Prednisone in Participants With Rheumatoid Arthritis
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Study Overview
Official Title:
A New Timed-Release Tablet Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis- A Randomized Multi-Centre Double-Blind Active Controlled Study With Open Extension on the New Drug Only
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to investigate if low doses of prednisone MR formulation given at night and with active drug release at 2 am are more effective in controlling joint stiffness and other disease symptoms of rheumatoid arthritis than standard IR prednisone given in the morning
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None